THE World Health Organization (WHO) recommended the two-drug treatment cocktail, casirivimab/imdevimab, for people with COVID-19. HealthTimes Reporter The development comes in the midst of calls by the Doctors Without Borders (MSF) on the US pharmaceutical corporation Regeneron, the manufacturer and patent holder of these drugs, to take immediate actions to ensure the medications are affordable and accessible for everyone who needs them and forego any monopoly on these new treatments. Given the massive need for COVID-19 medicines around the world, Regeneron should make casirivimab and imdevimab available at a reasonable…
Read MoreWHO Recommends Newest COVID-19 Treatment…As MSF Calls For Equal Access To The Medications
